Filing Flows › Teladoc Health (TDOC) › Capital expenditures
Teladoc Health (TDOC) capital expenditures by quarter
Teladoc Health's capital expenditures were $1.2M in Q3 2026 (third quarter 2026), +31% from Q2 2026. Over the last 7 quarters it ranged from $928K (Q2 2026) to $2.7M (Q1 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.2M | +31% | -47% |
| Q2 2026 | $928K | -44% | -27% |
| Q1 2026 | $1.7M | -37% | -39% |
| Q4 2025 | $2.6M | +15% | — |
| Q3 2025 | $2.3M | +80% | — |
| Q2 2025 | $1.3M | -53% | — |
| Q1 2025 | $2.7M | — | — |
Q3 2026 at a glance
Teladoc Health, Q3 2026: revenue $605M (-3% year over year), operating margin -4.6%, net loss $26.9M, operating cash flow $106M. The chart follows the revenue to costs, profit and cash.
Questions
What is Teladoc Health's capital expenditures?
Teladoc Health's capital expenditures were $1.2M in Q3 2026 (third quarter 2026), +31% from Q2 2026.
How has Teladoc Health's capital expenditures changed?
Over the last 7 quarters it ranged from $928K (Q2 2026) to $2.7M (Q1 2025).